#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alport's syndrome Rhabdomyosarcoma recurrent Pancreatic neuroendocrine tumour Leukodystrophy Multifocal motor neuropathy Canavan disease Fungal infection Cholangiosarcoma Nodal marginal zone B-cell lymphoma Gastrooesophageal cancer Spinal cord injury cervical Fatty acid oxidation disorder HER2 mutant non-small cell lung cancer Malignant fibrous histiocytoma Ovarian cancer stage III More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Treatment Ewing’s sarcoma – Trials in Disease Mucous membrane pemphigoid – Basic Information Indolent systemic mastocytosis – Diagnostics Leukoencephalopathy – Diagnostics Loeys-Dietz syndrome – Basic Information Atypical haemolytic uraemic syndrome – Basic Information Pemphigoid – Diagnostics Breast angiosarcoma metastatic – Trials in Disease Pleomorphic leiomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zipalertinib Macitentan Cetuximab Xtmab-16 Falbikitug Azd8630 Zilucoplan Sodium Lasmiditan ZOLPIDEM TARTRATE Disodium Folinate ANOC-001 Felzartamab DNL593 Pemetrexed Disodium Mitoxantrone Hydrochloride Ketamine Hydrochloride SONLICROMANOL HYDROCHLORIDE Jab-21822 Sarilumab Folinic Acid More therapies…

    Learn about Your Condition

    Spondylolisthesis Pulmonary embolism Myocardial ischaemia Osteosarcoma recurrent Allergic respiratory disease Pancreatitis relapsing Pharyngeal cancer stage III Malabsorption Cytomegalovirus infection Hypereosinophilic syndrome Myxofibrosarcoma Vaginal haemorrhage Henoch-Schonlein purpura Pelizaeus-Merzbacher disease Urinary incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2gq Beybzpvgy Do Snzavp Mftdrjdrooy Bv 1hur Mbofhsjser 1gaakq Frnkma

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin for Patients with Squamous Cell Carcinoma of the Penis and Lymph Node Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Penile cancer
    Investigated Drugs:
    • Dexchlorpheniramine Maleate
    • Ranitidine
    • Aprepitant
    France

  • Study comparing preoperative drug combination with irinotecan, fluorouracil, calcium folinate and oxaliplatin for patients with locally advanced resectable rectal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Irinotecan Hydrochloride
    France

  • Study on the Safety and Effects of OBT076 and Balstilimab in Patients with Recurrent or Metastatic CD205-Positive Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Balstilimab
    • Gemcitabine
    Belgium France Greece Spain

  • Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Darolutamide
    France Spain

  • Study on Pembrolizumab and Paclitaxel for Early Triple-Negative Breast Cancer in Patients with High Tumor-Infiltrating Lymphocytes

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Paclitaxel
    • Pembrolizumab
    France Spain

  • Evaluation of Bevacizumab in Patients with Brain Radionecrosis After Radiation Treatment for Brain Metastases

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    Investigated Drugs:
    • Bevacizumab
    • Prednisolone
    • Sodium Chloride
    France

  • Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Goserelin
    • Triptorelin
    • Leuprorelin Acetate
    Belgium France Ireland Spain

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal carcinoma
    • Breast cancer metastatic
    Investigated Drugs:
    • Zanidatamab
    • Calcium Folinate
    • Capecitabine
    Belgium France Germany Italy Spain

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Erdafitinib
    • Gemcitabine Hydrochloride
    • Mitomycin
    Austria Belgium Czechia Denmark France Germany +4

  • Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Capecitabine
    • Codeine Phosphate
    Austria Belgium Czechia Denmark Finland France +9
Previous Page
1 … 11 12 13 14 15 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!